Pavel Strnad, Nicolien M Hanemaaijer, Chantal Rovers, Joost P H Drenth, Tom J G Gevers, Richard Taubert, Jordi Colmenero, Frederik Nevens, Renée Duijzer, Ron T Gansevoort, Bart van Hoek, Roser Torra, Patrick S Kamath, Lucas H P Bernts, Anja Geerts, Mahdi Salih, Maxime Ronot, Vincenzo Cardinale, Ed J Kuijper, Jan Halbritter, Minneke J Coenraad, Marie C Hogan, Silvio Nadalin, Juozas Kupcinskas, Tatsuya Suwabe, Valerie Vilgrain, Marten A Lantinga, Domenico Alvaro
Journal: The lancet. Gastroenterology & hepatology 2024;9(9):884-894
PMID: 38878785
Liver cyst infections often necessitate long-term hospital admission and are associated with considerable morbidity and mortality. We conducted a modified Delphi study to reach expert consensus for a clinical decision framework. The expert panel consisted of 24 medical specialists, including 12 hepatologists, from nine countries across Europe, North America, and Asia. The Delphi had three rounds. The first round (response rate 21/24 [88%]) was an online survey with questions constructed from literature review and expert opinion, in which experts were asked about their management preferences and rated possible management strategies for seven clinical scenarios. Experts also rated 14 clinical decision-making items for relevancy and defined treatment outcomes. During the second round (response rate 13/24 [54%]), items that did not reach consensus and newly suggested themes were discussed in an online panel meeting. In the third round (response rate 16/24 [67%]), experts voted on definitions and management strategies using an online survey based on previous answers. Consensus was predefined as a vote threshold of at least 75%. We identified five subclassifications of liver cyst infection according to cyst phenotypes and patient immune status and consensus on episode definitions (new, persistent, and recurrent) and criteria for treatment success or failure was reached. The experts agreed that fever and elevated C-reactive protein are pivotal decision-making items for initiating and evaluating the management of liver cyst infections. Consensus was reached on 26 management statements for patients with liver cyst infections across multiple clinical scenarios, including two treatment algorithms, which were merged into one after comments. We provide a clinical decision framework for physicians managing patients with liver cyst infections. This framework will facilitate uniformity in the management of liver cyst infections and can constitute the basis for the development of future guidelines.
Copyright © 2024 Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies.
Medical:
Research Materials:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.